![A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89 | Inorganic Chemistry A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89 | Inorganic Chemistry](https://pubs.acs.org/cms/10.1021/acs.inorgchem.0c01629/asset/images/medium/ic0c01629_0001.gif)
A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89 | Inorganic Chemistry
![IJMS | Free Full-Text | [68Ga]Ga-DFO-c(RGDyK): Synthesis and Evaluation of Its Potential for Tumor Imaging in Mice IJMS | Free Full-Text | [68Ga]Ga-DFO-c(RGDyK): Synthesis and Evaluation of Its Potential for Tumor Imaging in Mice](https://www.mdpi.com/ijms/ijms-22-07391/article_deploy/html/images/ijms-22-07391-sch003.png)
IJMS | Free Full-Text | [68Ga]Ga-DFO-c(RGDyK): Synthesis and Evaluation of Its Potential for Tumor Imaging in Mice
![Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET | SpringerLink Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-016-3499-x/MediaObjects/259_2016_3499_Fig1_HTML.gif)
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET | SpringerLink
![IJMS | Free Full-Text | [68Ga]Ga-DFO-c(RGDyK): Synthesis and Evaluation of Its Potential for Tumor Imaging in Mice IJMS | Free Full-Text | [68Ga]Ga-DFO-c(RGDyK): Synthesis and Evaluation of Its Potential for Tumor Imaging in Mice](https://www.mdpi.com/ijms/ijms-22-07391/article_deploy/html/images/ijms-22-07391-g001.png)
IJMS | Free Full-Text | [68Ga]Ga-DFO-c(RGDyK): Synthesis and Evaluation of Its Potential for Tumor Imaging in Mice
![Site-specifically labeled 89Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model Site-specifically labeled 89Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model](https://www.thno.org/v09/p4409/toc.jpg)